FCGR2B and systemic lupus erythematosus: Furthermore, Dex-NPs produced great therapeutic effects in Fcgr2b-/- lupus-prone mice by mediating the selective targeting to DCs probably in a particle size-dependent manner and, as a consequence, inducing Treg expansion and antigen-specific immune tolerance.